Monthly Newsletter from the Arizona Asthma Coalition

The Stock Inhaler for Schools Program Newsletter 

A Message from the Stock Inhalers for Schools Team: We hope you had a wonderful break and look forward to working with you over the next semester! Now is a good time to check supply inventory and confirm that staff are reporting stock inhaler events in the appropriate data reporting portal. If your inhaler will expire soon, make sure to request more supplies. 

Read More

Breathing Easy in Maricopa County, Arizona: Empowering K-12 Schools With a Novel Nurse Coaching Model to Facilitate Implementation of a County-Wide School-Based Stock Albuterol Inhaler Program

KXCI Tucson

To reduce chronic school absenteeism and morbidity and mortality among school-aged children, the prompt administration of albuterol sulfate in schools remains vital. School-based stock inhaler programs are a practical approach to ensure equitable access to life-saving rescue medication for students. 

Read More

Social and environmental determinants of health inequities in childhood asthma

The Lancet


Asthma represents a substantial health burden in childhood globally, with minoritised populations being disproportionately impacted. Recent literature has increasingly linked social determinants of health to disparities in asthma prevalence, severity, and outcome. As defined by WHO, social determinants of health are non-medical factors that include the conditions that people are “born, grow, work, live, and age” in, and the economic policies and systems that influence health and life expectancy.

Read More

Why a common asthma drug will now carry extra safety warnings about depression

The Conversation

Australia’s Therapeutic Goods Administration (TGA) recently issued a safety alert requiring extra warnings to be included with the asthma and hay fever drug montelukast. The warnings are for users and their families to look for signs of serious behaviour and mood-related changes, such as suicidal thoughts and depression. The new warnings need to be printed at the start of information leaflets given to both patients and health-care providers (sometimes called a “boxed” warning).

Read More

2025 State Honor Roll™ of Asthma and Allergy Policies for Schools

Shared from Asthma and Allergy Foundation of America

The 2025 State Honor Roll™ of Asthma and Allergy Policies for Schools identifies the states with the best public policies for people with asthma, food allergies, anaphylaxis and related allergic diseases in U.S. elementary, middle and high schools.

Read More

Experts Urge Those with Asthma to Take Extra Care from Wildfire Risks to Lungs

American College of Allergy, Asthma and Immunology

Wildfires are an annual risk to people in many different parts of the United States. When smoke spreads across large portions of the country, those with respiratory illnesses such as asthma need to be alert to the effects of smoke on their breathing.

Read More

Arizona says GlaxoSmithKline's greed endangered kids with asthma

Arizona Republic

Arizona sued drug manufacturer GlaxoSmithKline over what it calls deceptive practices involving the inhaled corticosteroid Flovent that endangered asthma patients. The lawsuit filed Thursday in Maricopa County Superior Court by Arizona Attorney General Kris Mayes, citing the Arizona Consumer Fraud Act, says that the London-based multinational company was motivated by greed when it discontinued a widely used medication, Flovent (fluticasone propionate).

Read More

Join the Arizona Asthma Coalition

As a nonprofit partnership since 1996, AAC has worked together with concerned stakeholders including public health, environmental quality, managed care, education, individual physicians and nurses, hospitals, foundations, families and other colleagues. Become a member of the Arizona Asthma Coalition or renew your membership and help us continue this important work.

Join or renew here

Arizona Asthma Coalition

azasthma.org | 480-447-6978

839 W. Congress St.

Tucson, AZ 85745 

Unsubscribe